Impact Factor
2.06
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.72
40 total citations
h5-index
8
h5 depth signal
Cited share
43.9%
25 of 57
Total citations
40
Citation footprint
Metric signal
0.97
External metric anchor
Self-citation
2.5%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
246
Iran
39
Pakistan
20
United Kingdom
19
Italy
9
Citing Fields of Research
Cardiology
327
Autonomic Function
39
Hematology
21
Patient Care
20
Vascular Disorders
18
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
945
Articles tracked across the journal lifetime
Indexed publication set
57
25 cited publications
Last 12 months
34
3.8 publications/month
Open access share
8.8%
3 OA publications in the last year
Leading citing country
United States
246 citing publications
Leading citing field
Cardiology
327 citing publications
Latest tracked publication
24 September 2026
10 recent records available
Coverage & Indexing History
v6n1, Mar. 2007-
v6n1, Mar. 2007-
Research Focus & Classification
Indexed Subjects
Cardiology
Broad Categories
Cardiology
MeSH Descriptors
Cardiovascular Diseases
Evidence-Based Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/hpc.0000000000000440
Open DOI
Significance of platelet volume indices in acute coronary syndrome
Acute coronary syndrome (ACS) is a leading global cause of mortality, driven by platelet-mediated atherothrombosis; early diagnosis improves outcomes. This study aimed to evaluate platelet volume indices, including mean platelet volume (...
02
DOI 10.1097/hpc.0000000000000438
Open DOI
Effect of Influenza Vaccination on Major Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Cardiovascular disease remains the leading global cause of mortality despite advances in preventive therapies. Influenza infection is increasingly recognized as a trigger for acute cardiovascular events, prompting interest in influenza v...
03
DOI 10.1097/hpc.0000000000000436
Open DOI
Angiography-Derived vs Wire-Based Physiological Assessment in Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
This study aimed to determine whether angiography-based physiological assessment yields clinical outcomes comparable to those of conventional wire-based pressure measurements in patients with coronary artery disease (CAD) undergoing eval...
04
DOI 10.1097/hpc.0000000000000439
Open DOI
Redefining atrial fibrillation treatment success: patient-defined goals for arrhythmia burden and health-related quality of life
Background: Despite the use of atrial fibrillation (AF) cutoff of 30s as the standard for success in most AF clinical trials, patients consider an AF Severity Scale (AFSS) of ≤ 5 or AF duration ≤ 1 hour as treatment success. Prevalence a...
05
DOI 10.1097/hpc.0000000000000441
Open DOI
Contemporary Evaluation and Management Strategies for Tricuspid Regurgitation
Background: Tricuspid regurgitation (TR) is a common but historically under-recognized valvular heart disease. Although mild to moderate TR was long considered benign, accumulating evidence indicates that clinically significant TR is ass...
06
DOI 10.1097/hpc.0000000000000437
Open DOI
Sodium-Glucose Cotransporter-2 Inhibitor Use and Outcomes Following Transcatheter Aortic Valve Replacement: A Propensity-Score Matched Analysis
Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to improve outcomes across all heart failure (HF) phenotypes, but their role in patients undergoing transcatheter aortic valve replacement (TAVR) remains limi...
07
DOI 10.1097/hpc.0000000000000428
Open DOI
Exercise Training and Cardiac Remodeling in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and a leading cause of sudden cardiac death in young individuals and athletes. Historically, exercise restrictions were advised because of concerns about arrhy...
08
DOI 10.1097/hpc.0000000000000429
Open DOI
Door-to-Electrocardiogram Time Disparities in Acute Coronary Syndrome: Predictors and Clinical Outcomes in a Contemporary Community Hospital Cohort
Background: Door-to-electrocardiogram (D2E) time is a critical quality metric in evaluating patients with suspected acute coronary syndromes (ACS), yet adherence to the ≤10-minute benchmark remains suboptimal. This study aimed to quantif...
09
DOI 10.1097/hpc.0000000000000425
Open DOI
Aspirin Withdrawal Before 30 Days After PCI in Acute Coronary Syndrome and Early Myocardial Infarction Risk: A Systematic Review and Meta-analysis
Background: Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is the standard of care after percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS). Although aspirin discontinuation after at least 1 mo...
10
DOI 10.1097/hpc.0000000000000432
Open DOI
Pathway for the Diagnosis and Management of Pericardial Disease: Contemporary Perspective
Pericardial disease represents a diverse clinical spectrum, including acute pericarditis, pericardial effusion, cardiac tamponade, effusive–constrictive pericarditis (CP), and CP, which vary significantly in presentation, urgency, and ma...
Bibliographical & Catalog Notes
Latest issue consulted: Vol. 2, no. 1 (Mar. 2003).
Title from cover.
"A journal of evidence-based medicine."
Print issues ceased with v. 19 (2020).
Also issued online.